| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,362 |
2,962 |
$340K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,425 |
3,010 |
$231K |
| 99215 |
Prolong outpt/office vis |
396 |
379 |
$59K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
697 |
692 |
$21K |
| 90686 |
|
667 |
663 |
$4K |
| 96127 |
|
907 |
887 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
239 |
205 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
193 |
191 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
347 |
346 |
$3K |
| 99205 |
Prolong outpt/office vis |
13 |
13 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
85 |
84 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
113 |
108 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
14 |
14 |
$1K |
| 99408 |
|
26 |
26 |
$839.80 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
12 |
12 |
$731.36 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15 |
14 |
$678.45 |
| 90656 |
|
74 |
74 |
$565.11 |
| 81025 |
|
27 |
26 |
$206.82 |
| 99173 |
|
56 |
56 |
$136.79 |
| 81003 |
|
68 |
66 |
$136.00 |
| 96160 |
|
104 |
104 |
$0.00 |
| 1111F |
|
40 |
40 |
$0.00 |